| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e7aa001f3235c07b0298867908d45e21 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1205 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-12 |
| filingDate |
2001-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00109437a3575c1423b71490701dee9c |
| publicationDate |
2001-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0153793-A2 |
| titleOfInvention |
A novel steroid hormone receptor interacting protein kinase |
| abstract |
The present invention features a novel p21-activated kinase that interacts with steroid hormone receptors, the steroid hormone receptor interacting p21-activated kinase (PAKSI). In general, the invention provides methods of inhibiting hormone related cancers. More particularly, the present invention relates to inhibiting prostate cancer and breast cancer. The present invention further provides methods of activating the therapeutic effects of steroid hormone receptors, particularly the estrogen receptor. Alternatively, the present invention provides methods of diagnosing steroid hormone receptor-related diseases. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9945864-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022099676-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006507835-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1575997-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20170006289-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016109454-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1575997-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2055786-A3 |
| priorityDate |
2000-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |